Clinical Trials on Pulmonary Fibrosis Secondary to Systemic Sclerosis
Total 497 results
-
Novartis PharmaceuticalsTerminatedPulmonary Fibrosis Secondary to Systemic Sclerosis
-
Cliniques universitaires Saint-Luc- Université...Frederic Thys,MD,PhDWithdrawnARF Secondary to COPD Exacerbation | ARF Secondary to Cardiogenic Acute Pulmonary OedemaBelgium
-
W. Leroy GriffingRecruitingSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
Universidad de la SabanaFundación Neumologica Colombiana; Stem Medicina Regenerativa; Innocell SASAvailablePulmonary Fibrosis | Pulmonary Hypertension | Systemic Sclerosis PulmonaryColombia
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLong-term Effects Secondary to Cancer Therapy in Children | Pulmonary ComplicationsUnited States
-
Genentech, Inc.RecruitingIdiopathic Pulmonary Fibrosis | Systemic Sclerosis With Lung InvolvementUnited States, Korea, Republic of, Australia, Spain, Italy, Israel, Taiwan, Belgium, Argentina, France, New Zealand, Brazil, Greece, Poland, Chile, South Africa, Canada
-
Eicos Sciences, Inc.CompletedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited States
-
Eicos Sciences, Inc.CompletedRaynaud Phenomenon Secondary to Systemic SclerosisUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedRaynaud Phenomenon Secondary to Systemic SclerosisFrance
-
ActelionCompletedRaynaud's Phenomenon Secondary to Systemic SclerosisGermany, France, United Kingdom
-
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences...CompletedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited States
-
Casa Sollievo della Sofferenza IRCCSNeurocenter of Southern Switzerland; Associazione Revert ONLUS; Fondazione Cellule...CompletedSecondary-progressive Multiple SclerosisItaly, Switzerland
-
BioMS Technology Corp.TerminatedMultiple Sclerosis, Secondary Progressive
-
Northwestern UniversityCompletedSystemic Sclerosis | Fibrosis LungUnited States
-
University College, LondonLondon School of Hygiene and Tropical Medicine; The Leeds Teaching Hospitals... and other collaboratorsActive, not recruitingSecondary Progressive Multiple Sclerosis (SPMS)United Kingdom
-
State University of New York at BuffaloCompletedSecondary-progressive Multiple SclerosisUnited States
-
University of UtahCompletedMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Novartis PharmaceuticalsActive, not recruitingActive Secondary Progressive Multiple SclerosisItaly
-
Novartis PharmaceuticalsTerminatedSecondary Progressive Multiple Sclerosis With Inflammatory Disease ActivitySwitzerland
-
PfizerArena is a wholly owned subsidiary of PfizerTerminatedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited Kingdom, United States
-
Tehran University of Medical SciencesCompletedMultiple Sclerosis | Mesenchymal Stem Cells | Secondary-Progressive Multiple SclerosisIran, Islamic Republic of
-
Stem Cell Medicine Ltd.WithdrawnSecondary Progressive Multiple Sclerosis (SPMS)Israel
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple Sclerosis (SPMS)Japan
-
All India Institute of Medical Sciences, New DelhiUnknownPulmonary Hypertension Secondary to Lung Disease and/or HypoxiaIndia
-
Tiziana Life Sciences LTDWithdrawnMultiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis
-
University of LincolnNottingham University Hospitals NHS TrustCompletedDepression | Secondary-progressive Multiple SclerosisUnited Kingdom
-
BayerCompletedSecondary Progressive Multiple Sclerosis (SPMS) | Relapsing Remitting Multiple Sclerosis (RRMS)Portugal
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
BiogenWithdrawn
-
University College London HospitalsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University of CalgaryRecruiting
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
University of NottinghamNottingham University Hospitals NHS TrustCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University College, LondonUniversity of Leeds; University of Sheffield; Medical Research Council; Queen Mary... and other collaboratorsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Isfahan University of Medical SciencesCompletedSecondary Progressive Multiple SclerosisIran, Islamic Republic of
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedSecondary Progressive Multiple SclerosisGermany
-
Tokyo UniversityJapan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.CompletedAutoimmune Diseases | Collagen Diseases | Scleroderma, Systemic | Lung Fibrosis | Skin SclerosisJapan
-
ShuGuang HospitalHubei Hospital of Traditional Chinese Medicine; Wuhan No.1 Hospital; Wuhan Third... and other collaboratorsCompletedPulmonary Fibrosis Due to COVID-19China
-
SanofiRecruitingRelapsing Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisBelgium
-
AB ScienceCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Relapse FreePoland, Spain, Bulgaria, France, Germany, Greece, Romania
-
National Institute of Allergy and Infectious Diseases...Novartis Pharmaceuticals; Autoimmunity Centers of ExcellenceCompletedSecondary Progressive Multiple SclerosisUnited States
-
Johns Hopkins UniversityHugo W. Moser Research Institute at Kennedy Krieger, Inc.CompletedSecondary Progressive Multiple SclerosisUnited States
-
University of CalgaryAlberta Innovates Health SolutionsCompletedMultiple Sclerosis, Secondary ProgressiveCanada
-
Imperial College LondonCompletedSecondary Progressive Multiple SclerosisUnited Kingdom